Skye Bioscience (SKYE)
US Market

Skye Bioscience (SKYE) Balance Sheet


Skye Bioscience Balance Sheet

Skye Bioscience's total assets for Q were $15.60M, an increase of 597.89% from the previous quarter. SKYE total liabilities were $13.91M for the fiscal quarter, a 38.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 9.02M$ 9.86M$ 2.67M$ 2.00M$ 1.96M
Total Liabilities
$ 12.12M$ 3.99M$ 2.22M$ 1.45M$ 17.52M
Total Equity Gross Minority
$ -3.01M$ 5.86M$ 450.79K$ 548.06K$ -15.56M
Total Capitalization
$ -3.01M$ 6.35M$ 1.88M$ 935.13K$ -14.20M
Preferred Stock Equity
Capital Lease Obligations
--$ 0.00--
Currency in USD

Skye Bioscience Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis